Fired Music Director Meets Supporters

Reported by: Evan White
Set Text Size SmallSet Text Size MediumSet Text Size LargeSet Text Size X-Large
Share
Updated: 1/11 1:15 am
Rochester, N.Y.—Arild Remmereit spoke for less than ten minutes, but during that time he struck a chord with fans, yet again.

“He is a world class musician and a world class person,” said Jan Miller, a supporter,

Remmereit’s contract was terminated by the board members of the Rochester Philharmonic Orchestra because of differences with RPO leadership.

In his comments to a crowd of more than 100 supporters at Monroe County’s central library, Remmereit thanked the community and asked supporters to channel their emotions.

“May this passion be channeled toward reaching the obvious goal; a great future for the Rochester Philharmonic Orchestra,” said Remmereit.

“It is a shame it had to end this way,” said Mark Berry, Vice President of Marketing & Communications for the RPO.

Berry said Thursday that the divorce between the RPO and Remmereit had nothing to do with clashes between the music director and leaders, but an inability for Remmereit to do his job properly.

“When it came down to how it would affect the music and how it affected the musicians, the board had to take action,” said Berry.

Two board members resigned in light of the contract termination.

This may not be the final time fans will see Remmereit. He is scheduled to perform for the RPO February 28th and March 2nd, according to Berry. Both sides are still negotiation the end of Remmereit’s time at the RPO, but it is possible that the popular director performs again. His contract termination is slated to take affect August 31st.

“Anything is possible,” said Glenn Pezzulo, Remmereit’s attorney. “I can’t tell you whether it is likely or not."
Share
State News
Face Transplant Surgery - 27 Hours
Warsaw, Poland (AP) - Doctors in Poland say they have performed an urgent total face transplant on a 33-year-old man whose face was torn off in an accident which also crushed his jaws.
National News
FDA panel backs experimental new insomnia drug
A federal panel of medical experts says that an experimental insomnia drug from Merck & Co Inc. appears safe and effective, despite evidence from company trials that the pill can cause daytime sleepiness and difficulty driving.
Inergize Digital This site is hosted and managed by Inergize Digital.
Mobile advertising for this site is available on Local Ad Buy.